Repetitive viral infection accentuates airway wall remodelling

重复的病毒感染加剧气道壁重塑

基本信息

  • 批准号:
    nhmrc : 464815
  • 负责人:
  • 金额:
    $ 18.05万
  • 依托单位:
  • 依托单位国家:
    澳大利亚
  • 项目类别:
    NHMRC Project Grants
  • 财政年份:
    2007
  • 资助国家:
    澳大利亚
  • 起止时间:
    2007-01-01 至 2009-12-31
  • 项目状态:
    已结题

项目摘要

In the asthmatic lung structural changes or remodelling occur, which are thought to contribute to the abnormal functioning of the airways. These remodelling events which occur in the asthmatic airway include increased deposition of proteins which form the scaffolding of the airways (the extracellular matrix ECM proteins), and an increased mass of bronchial smooth muscle cells. Many of these critical structural changes are not reversed or prevented with current asthma therapy. Remodelling is an important process in both the development and progression of asthma. The reason why remodelling occurs in the lungs of people with asthma is not known. It is thought that persistent inflammation drives the remodelling process; however remodelling can perpetuate inflammation, thereby creating a cyclic series of events. Furthermore we have shown that cells from non-asthmatic volunteers which are grown on asthmatic ECM change to become more like cells from asthmatic subjects. Viruses which infect the lungs may play a role in the development of asthma, and in the increased remodelling which is observed. Many common respiratory viruses are capable of infecting lung cells, eg epithelial cells, which evokes an inflammatory response. I will investigate if viral infection can alter the remodelling process, using lung cells isolated from asthmatic and non-asthmatic volunteers. Furthermore, I will assess if current and novel treatments are effective in reducing the remodelling process. We have preliminary evidence that infection of lung epithelial cells with rhinovirus (the common cold virus) alters the amount of ECM deposited by these cells. I hypothesise that this process will be increased in cells from volunteers with asthma compared to non-asthma. As current therapeutics are unlikely to be able to reverse these remodelling events these experiments will enable the development of new therapeutics which can target this important aspect of airway disease.
在哮喘中,发生肺结构变化或重塑,这被认为是导致气道功能异常的原因。在哮喘气道中发生的这些重塑事件包括形成气道支架的蛋白质(细胞外基质ECM蛋白)沉积增加,以及支气管平滑肌细胞质量增加。这些关键的结构变化中有许多在目前的哮喘治疗中无法逆转或预防。重塑是哮喘发生和发展的重要过程。哮喘患者肺部发生重塑的原因尚不清楚。据认为,持续的炎症驱动重塑过程;然而,重塑可以使炎症永久化,从而产生一系列循环事件。此外,我们已经表明,在哮喘ECM上生长的来自非哮喘志愿者的细胞变得更像来自哮喘受试者的细胞。感染肺部的病毒可能在哮喘的发展中起作用,并在观察到的重塑增加中起作用。许多常见的呼吸道病毒能够感染肺细胞,例如上皮细胞,引起炎症反应。我将使用从哮喘和非哮喘志愿者中分离的肺细胞来研究病毒感染是否可以改变重塑过程。此外,我将评估目前和新的治疗方法是否能有效减少重塑过程。我们有初步证据表明,鼻病毒(普通感冒病毒)感染肺上皮细胞会改变这些细胞沉积的ECM数量。我假设,与非哮喘志愿者相比,哮喘志愿者的细胞中这一过程会增加。由于目前的治疗方法不太可能逆转这些重塑事件,这些实验将能够开发新的治疗方法,其可以靶向气道疾病的这一重要方面。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

A/Pr Brian Oliver其他文献

A/Pr Brian Oliver的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('A/Pr Brian Oliver', 18)}}的其他基金

Elucidation of the Aetiology of Airway Remodelling in COPD
慢性阻塞性肺病 (COPD) 气道重塑病因学的阐明
  • 批准号:
    nhmrc : 1104704
  • 财政年份:
    2016
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Project Grants
Elucidation of the Aetiology of Airway Remodelling in COPD
慢性阻塞性肺病 (COPD) 气道重塑病因学的阐明
  • 批准号:
    nhmrc : GNT1104704
  • 财政年份:
    2016
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Project Grants
Novel methods to treat airway remodelling
治疗气道重塑的新方法
  • 批准号:
    nhmrc : GNT1110368
  • 财政年份:
    2016
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Career Development Fellowships
Novel methods to treat airway remodelling
治疗气道重塑的新方法
  • 批准号:
    nhmrc : 1110368
  • 财政年份:
    2016
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Career Development Fellowships
Mechanisms of impaired bronchodilator response associated with fatty acid intake in obese asthma
肥胖哮喘中与脂肪酸摄入相关的支气管扩张剂反应受损的机制
  • 批准号:
    nhmrc : 1081355
  • 财政年份:
    2015
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Project Grants
Mechanisms of impaired bronchodilator response associated with fatty acid intake in obese asthma
肥胖哮喘中与脂肪酸摄入相关的支气管扩张剂反应受损的机制
  • 批准号:
    nhmrc : GNT1081355
  • 财政年份:
    2015
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Project Grants
Elucidating the role of mast cell tryptases in chronic obstructive pulmonary disease and Crohn's disease
阐明肥大细胞类胰蛋白酶在慢性阻塞性肺病和克罗恩病中的作用
  • 批准号:
    nhmrc : 1023131
  • 财政年份:
    2012
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Project Grants
Novel targets to treat airway fibrosis
治疗气道纤维化的新靶点
  • 批准号:
    nhmrc : 1026880
  • 财政年份:
    2012
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Career Development Fellowships
Exploring the role of respiratory virus infections in childhood asthma exacerbations
探索呼吸道病毒感染在儿童哮喘急性发作中的作用
  • 批准号:
    nhmrc : 633238
  • 财政年份:
    2010
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Project Grants
A new non-invasive diagnostic technique based on detection of exhaled respiratory pathogens.
一种基于呼出呼吸道病原体检测的新型非侵入性诊断技术。
  • 批准号:
    nhmrc : 571380
  • 财政年份:
    2009
  • 资助金额:
    $ 18.05万
  • 项目类别:
    NHMRC Development Grants

相似国自然基金

大豆MYB(v-myb avian myeloblastosis viral oncogene homolog)转录因子基因对大豆异黄酮合成调控的研究
  • 批准号:
    31371641
  • 批准年份:
    2013
  • 资助金额:
    15.0 万元
  • 项目类别:
    面上项目
植物病毒壳体"智能"纳米载体靶向肿瘤细胞的研究
  • 批准号:
    30973685
  • 批准年份:
    2009
  • 资助金额:
    35.0 万元
  • 项目类别:
    面上项目
中国棉铃虫单核衣壳核多角体病毒膜融合蛋白的结构和功能研究
  • 批准号:
    30300012
  • 批准年份:
    2003
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Strategies for next-generation flavivirus vaccine development
下一代黄病毒疫苗开发策略
  • 批准号:
    10751480
  • 财政年份:
    2024
  • 资助金额:
    $ 18.05万
  • 项目类别:
Identification of immune cells protecting from lethal viral infection in the central nervous system
鉴定中枢神经系统免受致命病毒感染的免疫细胞
  • 批准号:
    22KJ1176
  • 财政年份:
    2023
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Administrative Core
行政核心
  • 批准号:
    10549476
  • 财政年份:
    2023
  • 资助金额:
    $ 18.05万
  • 项目类别:
Antibody Core
抗体核心
  • 批准号:
    10549477
  • 财政年份:
    2023
  • 资助金额:
    $ 18.05万
  • 项目类别:
Targeting HIV-specific CAR T cells to the gut for the durable remission of HIV
将 HIV 特异性 CAR T 细胞靶向肠道以实现 HIV 的持久缓解
  • 批准号:
    10527172
  • 财政年份:
    2023
  • 资助金额:
    $ 18.05万
  • 项目类别:
Evaluating EEG as a diagnostic and prognostic biomarker in Malawian children with febrile coma
评估脑电图作为马拉维热昏迷儿童的诊断和预后生物标志物
  • 批准号:
    10523296
  • 财政年份:
    2023
  • 资助金额:
    $ 18.05万
  • 项目类别:
Microscopy and Image Analysis Core
显微镜和图像分析核心
  • 批准号:
    10557025
  • 财政年份:
    2023
  • 资助金额:
    $ 18.05万
  • 项目类别:
Nursing homes' visitation bans during the COVID-19 pandemic: Effectiveness and consequences.
COVID-19 大流行期间疗养院的探视禁令:有效性和后果。
  • 批准号:
    10635829
  • 财政年份:
    2023
  • 资助金额:
    $ 18.05万
  • 项目类别:
Anti-flavivirus B cell response analysis to aid vaccine design
抗黄病毒 B 细胞反应分析有助于疫苗设计
  • 批准号:
    10636329
  • 财政年份:
    2023
  • 资助金额:
    $ 18.05万
  • 项目类别:
Ionic Liquids of tenofovir prodrugs for improved oral bioavailability and antiviral efficacy
替诺福韦前药离子液体可提高口服生物利用度和抗病毒功效
  • 批准号:
    10699620
  • 财政年份:
    2023
  • 资助金额:
    $ 18.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了